Andlauer Healthcare Group (TSE:AND) Price Target Raised to C$49.00

Andlauer Healthcare Group (TSE:ANDFree Report) had its price objective increased by National Bankshares from C$45.00 to C$49.00 in a research note issued to investors on Tuesday morning,BayStreet.CA reports. The firm currently has a sector perform rating on the stock.

AND has been the subject of several other research reports. Scotiabank upped their price target on shares of Andlauer Healthcare Group from C$43.00 to C$44.00 in a research report on Thursday, November 7th. TD Securities increased their target price on shares of Andlauer Healthcare Group from C$53.00 to C$54.00 and gave the company a “buy” rating in a research report on Thursday, November 7th. Three analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of C$48.86.

Read Our Latest Research Report on AND

Andlauer Healthcare Group Price Performance

Shares of AND opened at C$45.25 on Tuesday. The company has a 50 day moving average price of C$44.27 and a 200-day moving average price of C$41.76. Andlauer Healthcare Group has a fifty-two week low of C$36.43 and a fifty-two week high of C$48.00. The stock has a market capitalization of C$1.80 billion, a PE ratio of 27.25 and a beta of 0.66. The company has a debt-to-equity ratio of 39.31, a quick ratio of 1.66 and a current ratio of 1.44.

About Andlauer Healthcare Group

(Get Free Report)

Andlauer Healthcare Group Inc, a supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States. The company operates in two segments, Specialized Transportation and Healthcare Logistics.

Recommended Stories

Analyst Recommendations for Andlauer Healthcare Group (TSE:AND)

Receive News & Ratings for Andlauer Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Andlauer Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.